{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:12:50Z","timestamp":1780726370106,"version":"3.54.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s40261-022-01228-5","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T10:03:17Z","timestamp":1673344997000},"page":"141-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Assessment of Hormonal Contraceptive Utilization and Associated Odds of Hypercoagulopathy in Patients with Venous Malformations Using a National Claims Database"],"prefix":"10.1007","volume":"43","author":[{"given":"Jami","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie F.","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-6807","authenticated-orcid":false,"given":"Joyce M. C.","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"issue":"9","key":"1228_CR1","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1016\/j.jpedsurg.2011.05.006","volume":"46","author":"AK Greene","year":"2011","unstructured":"Greene AK, Liu AS, Mulliken JB, Chalache K, Fishman SJ. Vascular anomalies in 5621 patients: guidelines for referral. J Pediatr Surg. 2011;46(9):1784\u20139.","journal-title":"J Pediatr Surg"},{"issue":"8","key":"1228_CR2","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1001\/archderm.140.8.979","volume":"140","author":"EF Mathes","year":"2004","unstructured":"Mathes EF, Haggstrom AN, Dowd C, Hoffman WY, Frieden IJ. Clinical characteristics and management of vascular anomalies: findings of a multidisciplinary vascular anomalies clinic. Arch Dermatol. 2004;140(8):979\u201383.","journal-title":"Arch Dermatol"},{"issue":"7","key":"1228_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1001\/archderm.144.7.861","volume":"144","author":"E Mazoyer","year":"2008","unstructured":"Mazoyer E, Enjolras O, Bisdorff A, Perdu J, Wassef M, Drouet L. Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients. Arch Dermatol. 2008;144(7):861\u20137.","journal-title":"Arch Dermatol"},{"issue":"2","key":"1228_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1055\/s-0036-1582241","volume":"27","author":"J Hung","year":"2016","unstructured":"Hung J, Leung M, Liu C, Fung D, Poon W, Yam F, et al. Venous malformation and localized intravascular coagulopathy in children. Eur J Pediatr Surg. 2016;27(2):181\u20134.","journal-title":"Eur J Pediatr Surg"},{"issue":"2","key":"1228_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jpedsurg.2017.11.030","volume":"53","author":"YCL Leung","year":"2018","unstructured":"Leung YCL, Leung MWY, Yam SD, Hung JWS, Liu CSW, Chung LY, et al. D-dimer level correlation with treatment response in children with venous malformations. J Pediatr Surg. 2018;53(2):289\u201392.","journal-title":"J Pediatr Surg"},{"issue":"11","key":"1228_CR6","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1001\/archdermatol.2009.296","volume":"145","author":"A Dompmartin","year":"2009","unstructured":"Dompmartin A, Ballieux F, Thibon P, Lequerrec A, Hermans C, Clapuyt P, et al. Elevated D-dimer level in the differential diagnosis of venous malformations. Arch Dermatol. 2009;145(11):1239\u201344.","journal-title":"Arch Dermatol"},{"issue":"5","key":"1228_CR7","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1258\/phleb.2009.009041","volume":"25","author":"A Dompmartin","year":"2010","unstructured":"Dompmartin A, Vikkula M, Boon LM. Venous malformation: update on aetiopathogenesis, diagnosis and management. Phlebology. 2010;25(5):224\u201335.","journal-title":"Phlebology"},{"issue":"7663","key":"1228_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0140-6736(70)92690-5","volume":"296","author":"L Goldman","year":"1970","unstructured":"Goldman L. Oral contraceptives and vascular anomalies. Lancet. 1970;296(7663):108\u20139.","journal-title":"Lancet"},{"issue":"1","key":"1228_CR9","first-page":"59","volume":"45","author":"D Bateson","year":"2016","unstructured":"Bateson D, Butcher BE, Donovan C, Farrell L, Kovacs G, Mezzini T, et al. Risk of venous thromboembolism in women taking the combined oral contraceptive: a systematic review and meta-analysis. Aust Fam Physician. 2016;45(1):59\u201364.","journal-title":"Aust Fam Physician"},{"issue":"18","key":"1228_CR10","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1001\/archinte.164.18.1965","volume":"164","author":"MPV Gomes","year":"2004","unstructured":"Gomes MPV, Deitcher SR. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med. 2004;164(18):1965.","journal-title":"Arch Intern Med"},{"key":"1228_CR11","volume-title":"Medical eligibility criteria for contraceptive use","author":"World Health Organization","year":"2010","unstructured":"World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: WHO Press; 2010.","edition":"4"},{"issue":"1","key":"1228_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4755-1-1","volume":"1","author":"R Kulier","year":"2004","unstructured":"Kulier R, Helmerhorst FM, Maitra N, G\u00fclmezoglu AM. Effectiveness and acceptability of progestogens in combined oral contraceptives: a systematic review. Reprod Health. 2004;1(1):1\u20139.","journal-title":"Reprod Health"},{"key":"1228_CR13","doi-asserted-by":"publisher","unstructured":"Stanford Center for Population Health Sciences. Optum SES (v5.0). Redivis. 2021. https:\/\/doi.org\/10.57761\/phra-vp46. Accessed 30 Oct 2021.","DOI":"10.57761\/phra-vp46"},{"issue":"6","key":"1228_CR14","first-page":"743","volume":"11","author":"LA Sech","year":"2015","unstructured":"Sech LA, Mishell DR Jr. Oral steroid contraception. Womens Health. 2015;11(6):743\u20138.","journal-title":"Womens Health"},{"issue":"2","key":"1228_CR15","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S1521-6926(03)00021-5","volume":"16","author":"KA Bremme","year":"2003","unstructured":"Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol. 2003;16(2):153\u201368.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"3","key":"1228_CR16","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0010-7824(01)00307-9","volume":"65","author":"\u00d8 Lidegaard","year":"2002","unstructured":"Lidegaard \u00d8, Edstr\u00f6m B, Kreiner S. Oral contraceptives and venous thromboembolism: a five-year national case-control study. Contraception. 2002;65(3):187\u201396.","journal-title":"Contraception"},{"key":"1228_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2890","volume":"339","author":"\u00d8 Lidegaard","year":"2009","unstructured":"Lidegaard \u00d8, L\u00f8kkegaard E, Svendsen AL, Agger C. Hormonal contraception and risk of venous thromboembolism: national follow-up study. BMJ. 2009;339: b2890.","journal-title":"BMJ"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-022-01228-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-022-01228-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T14:29:47Z","timestamp":1675693787000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-022-01228-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1228"],"URL":"https:\/\/doi.org\/10.1007\/s40261-022-01228-5","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"value":"1173-2563","type":"print"},{"value":"1179-1918","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"assertion":[{"value":"14 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received for the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Jami Wang, Mollie F. Qian, Michael R. Jeng, and Joyce M.C. Teng have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}},{"value":"All data were accessed through the Stanford PHS Data Core and fall under Stanford University\u2019s Institutional Review Board protocol (PHS-40974) for the use of de-identified data in clinical outcomes research.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The source data for this study were licensed by Stanford PHS from Optum and are not available for public sharing. However, these data are available through contractual purchase of the Clinformatics<sup>\u00ae<\/sup> Data Mart Database (OptumInsight, Eden Prairie, MN, USA).","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"The Stata code (devoid of Optum data) is available upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"MFQ performed the data analysis; JW, MFQ, MRJ, and JMCT participated in the study design and interpretation of the results; and JW, MFQ, MRJ, and JMCT contributed to the drafting and critical appraisal of the manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}